These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25716882)

  • 41. [IgG synthesis in the central nervous system in multiple sclerosis and other neurologic diseases. Measurement and validity].
    Safár J; Vymazal J; Tichý J; Růzicková V
    Cas Lek Cesk; 1985 Sep; 124(36):1131-6. PubMed ID: 4028102
    [No Abstract]   [Full Text] [Related]  

  • 42. Expression of the 14E antigen in glial cells in human normal and pathological central nervous system tissues.
    Newcombe J; Brar A; Li H; Cuzner ML
    Ann N Y Acad Sci; 1991; 633():556-8. PubMed ID: 1789578
    [No Abstract]   [Full Text] [Related]  

  • 43. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MS: a localized immune disease of the central nervous system.
    Calder V; Owen S; Watson C; Feldmann M; Davison A
    Immunol Today; 1989 Mar; 10(3):99-103. PubMed ID: 2472812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroinflammation: A common denominator for stroke, multiple sclerosis and Alzheimer's disease.
    Vries HE; Schwaninger M
    Biochim Biophys Acta; 2016 Mar; 1862(3):297-8. PubMed ID: 26748252
    [No Abstract]   [Full Text] [Related]  

  • 46. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dual role of CXCL8 in human CNS stem cell function: multipotent neural stem cell death and oligodendrocyte progenitor cell chemotaxis.
    Kelland EE; Gilmore W; Weiner LP; Lund BT
    Glia; 2011 Dec; 59(12):1864-78. PubMed ID: 22407782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased CXCL8 (IL-8) expression in Multiple Sclerosis.
    Lund BT; Ashikian N; Ta HQ; Chakryan Y; Manoukian K; Groshen S; Gilmore W; Cheema GS; Stohl W; Burnett ME; Ko D; Kachuck NJ; Weiner LP
    J Neuroimmunol; 2004 Oct; 155(1-2):161-71. PubMed ID: 15342208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis.
    Airas L; Mikkola J; Vainio JM; Elovaara I; Smith DJ
    J Neuroimmunol; 2006 Aug; 177(1-2):132-5. PubMed ID: 16806498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis.
    Butti E; Bergami A; Recchia A; Brambilla E; Del Carro U; Amadio S; Cattalini A; Esposito M; Stornaiuolo A; Comi G; Pluchino S; Mavilio F; Martino G; Furlan R
    Gene Ther; 2008 Apr; 15(7):504-15. PubMed ID: 18239607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study.
    Vercellino M; Votta B; Condello C; Piacentino C; Romagnolo A; Merola A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuroimmunol; 2008 Aug; 199(1-2):133-41. PubMed ID: 18539342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immune reactions in the central nervous system].
    Iivanainen M; Taskinen E
    Duodecim; 1986; 102(5):281-9. PubMed ID: 3486107
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 54. The CNS as a therapeutic target in multiple sclerosis.
    Antel JP
    Curr Neurol Neurosci Rep; 2008 Nov; 8(6):445-7. PubMed ID: 18957179
    [No Abstract]   [Full Text] [Related]  

  • 55. Chemokines and leukocyte traffic.
    Sallusto F; Baggiolini M
    Nat Immunol; 2008 Sep; 9(9):949-52. PubMed ID: 18711431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF; Martin R
    Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoimmune disease and the nervous system.
    Steinman L
    West J Med; 1992 Jun; 156(6):664-6. PubMed ID: 1615671
    [No Abstract]   [Full Text] [Related]  

  • 58. Chondroitin sulphate proteoglycans: extracellular matrix proteins that regulate immunity of the central nervous system.
    Haylock-Jacobs S; Keough MB; Lau L; Yong VW
    Autoimmun Rev; 2011 Oct; 10(12):766-72. PubMed ID: 21664302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell-mediated hypersensitivity and disease activity in multiple sclerosis.
    Sheremata W; Cosgrove JB; Robb P
    Trans Am Neurol Assoc; 1973; 98():306-9. PubMed ID: 4784962
    [No Abstract]   [Full Text] [Related]  

  • 60. Central nervous system infections - a potential complication of systemic immunotherapy.
    Hemmer B; Frohman E; Hartung HP; Stüve O
    Curr Opin Neurol; 2006 Jun; 19(3):271-6. PubMed ID: 16702834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.